Sunday, 20 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14437
Articles
Company
Biogen Reports 8% YOY Sales Growth in Q1 2025, Driven by Rare Disease Therapies
May 7, 2025
Company
Drug
Zhongsheng Pharma’s RAY1225 Shows Positive Results in Phase II Trials for Weight Loss and Blood Glucose Reduction
May 7, 2025
Company
Deals
Alchemab Therapeutics Licenses ATLX-1282 to Eli Lilly for ALS Treatment
May 7, 2025
Policy / Regulatory
China’s NMPA Releases Draft Guidelines for Development Risk Management Plan
May 7, 2025
Company
Drug
AstraZeneca’s Calquence Gains EU Approval for Mantle Cell Lymphoma
May 7, 2025
Company
Drug
Huadong Medicine’s HDM2005 Receives NMPA Approval for DLBCL Clinical Trial
May 7, 2025
Company
Fresenius Medical Care Reports 1% Revenue Growth in Q1 2025
May 7, 2025
Company
Drug
Innovent Biologics Completes First Dosing in Phase II Study for Efdamrofusp Alfa in DME
May 7, 2025
Company
Deals
EndoCell Secures RMB 200 Million in Financing to Advance Islet Regeneration Technology
May 7, 2025
Company
Medical Device
Beijing Wantai’s HIV Urine Self-Test Kit Gains WHO Prequalification
May 7, 2025
Company
Deals
Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex for Mexico
May 7, 2025
Company
Drug
Shuangcheng Pharma’s Generic Bivalirudin Approved by Australia’s TGA
May 7, 2025
1
2
…
371
372
373
374
375
…
1,203
1,204
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
